FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 1 filers reported holding FREELINE THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is - and the average weighting 5.7%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 1,324,364 | $20,673,000 | 7.35% |
| SECTORAL ASSET MANAGEMENT INC | 842,851 | $13,157,000 | 1.13% |
| TFG Asset Management GP Ltd | 730,000 | $11,395,000 | 1.05% |
| FRAZIER MANAGEMENT LLC | 550,000 | $8,586,000 | 0.77% |
| Eventide Asset Management | 2,343,304 | $35,620,000 | 0.70% |
| Novo Holdings A/S | 665,000 | $10,381,000 | 0.52% |
| Monashee Investment Management LLC | 94,911 | $1,482,000 | 0.32% |
| Ovata Capital Management Ltd | 37,500 | $585,000 | 0.21% |
| Woodline Partners LP | 206,413 | $3,222,000 | 0.11% |
| Hound Partners | 70,000 | $1,093,000 | 0.07% |